AKR1B10 and metabolic dysfunction-associated steatotic liver disease: While only CFHR4 is uniquely expressed in healthy liver (Extended Data Fig. 2), ADAMTSL2, AKR1B10 and TREM2 have been previously been reported to play a role in the progression of liver diseases and NAFLD.